KROS - Keros Therapeutics prices upsized stock offering to raise $140 million
2024-01-04 01:04:56 ET
More on Keros Therapeutics
- Keros Therapeutics: Interesting Early Data From A Promising Molecule (Downgrade)
- Keros falls after mid-stage data for blood cancer therapy
- Seeking Alpha’s Quant Rating on Keros Therapeutics
For further details see:
Keros Therapeutics prices upsized stock offering to raise $140 million